Submissions

Browse Submissions

Filter Results

CHPA’s argues both constitutional precedent and federal rules on class action lawsuits require classes that capture members who actually have a viable claim and potential right to recovery; not classes in which some consumers are even plausibly harmed.

Sep 7, 2021

PCPC and CHPA appreciate the opportunity to comment on FDA Notice of Intent to Prepare and Environmental Impact Statement to evaluate environmental effects for marketing certain OTC sunscreen products.

Jun 14, 2021

In keeping with the mission of the FDA Center for Drug Evaluation and Research’s Office of Surveillance and Epidemiology Division of Medication Error and Prevention Analysis, this CHPA member feedback is designed to minimize the risk of medication errors due to consumer confusion attributed to an OTC drug product name.

Jun 14, 2021

The American Cleaning Institute (ACI) and the Consumer Healthcare Products Association (CHPA) request that FDA withdraw its Guidance for Industry: Temporary Policy for Preparation of Certain Alcohol-Based Hand Sanitizer Products During the Public Health Emergency (COVID-19).

Apr 28, 2021

Supply chain resilience is essential to assure consumer healthcare products Americans depend on remain widely available, including in times of disease outbreaks or global crises.

Dec 23, 2020

The breadth of the proposed rule would create a heavy workload on agencies within HHS, diverting attention from more pressing work. CHPA requests an extension of the comment period

Dec 4, 2020

Enclosed are comments on the recent notice from the California Office of Environmental Health Hazard Assessment regarding 22 chemicals to be discussed at a meeting of the Developmental and Reproductive Toxicant Identification Committee. These comments address manganese.

Nov 16, 2020

These comments address the four parabens that are on the prioritization list. As these ingredients serve an important preservative function and have been extensively reviewed and approved by expert bodies, they should be considered low priority for DARTIC review.

Nov 16, 2020

These comments address titanium dioxide nanoparticles, which serve an important function in numerous consumer products, including sunscreens.

Nov 16, 2020

As FDA is recognized as an authoritative body by Proposition 65, we believe that OEHHA should await the outcome of FDA's review rather than bringing BP-3 to the DARTIC for review.

Nov 16, 2020

Filter Results